Please enable JavaScript to continue using this application.

Compare $ALXO vs $CMPX | Chartloom

Compare

$ALXO vs $CMPX

ALX Oncology Holdings Inc · Compass Therapeutics Inc.

ALXO

ALX Oncology Holdings Inc

CMPX

Compass Therapeutics Inc.

Compare $ALXO vs $CMPX

Comparing ALX Oncology Holdings Inc and Compass Therapeutics Inc.

ALXOALX Oncology Holdings Inc

CMPXCompass Therapeutics Inc.

ALXOALX Oncology Holdings Inc

Market cap

$168M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

8.7%

52W performance

-36.5%

FCF yield

-42.2%

CMPXCompass Therapeutics Inc.

Market cap

$179M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.51x

Rev growth (TTM)

—

YTD performance

-80.8%

52W performance

-74.5%

FCF yield

-31.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALXO

CMPX

Detailed metrics comparison

ALXO

ALX Oncology Holdings Inc

CMPX

Compass Therapeutics Inc.

Market Cap

ALXO$168M

CMPX$179M

Enterprise Value

ALXO$156M

CMPX$143M

Price

ALXO$1.25

CMPX$0.99

P/E Ratio

ALXON/A

CMPXN/A

P/S Ratio

ALXO46.09x

CMPX0.00x

EV/Sales

ALXO0.00x

CMPX0.00x

EV/EBITDA

ALXO0.00x

CMPX0.00x

P/B Ratio

ALXO1.24x

CMPX0.93x

P/FCF Ratio

ALXON/A

CMPXN/A

EV/FCF

ALXO-2.20x

CMPX-2.54x

PEG Ratio

ALXON/A

CMPXN/A

Forward P/E (NTM)

ALXON/A

CMPXN/A

Forward P/S (NTM)

ALXON/A

CMPX1.51x

Revenue (TTM)

ALXO$0

CMPX$0

Revenue Growth (YoY)

ALXON/A

CMPXN/A

Forward Rev Growth

ALXO357.6%

CMPX397.5%

Gross Margin (TTM)

ALXO9.0%

CMPX0.0%

Operating Margin (TTM)

ALXO0.0%

CMPX0.0%

EBITDA Margin (TTM)

ALXO0.0%

CMPX0.0%

Net Margin (TTM)

ALXO0.0%

CMPX0.0%

FCF Margin (TTM)

ALXON/A

CMPXN/A

Net Income (TTM)

ALXO$-81M

CMPX$-30M

FCF (TTM)

ALXO$-71M

CMPX$-56M

EPS (TTM)

ALXO-$0.60

CMPX$0.00

ROE (TTM)

ALXO-9030.0%

CMPX-2994.0%

ROA (TTM)

ALXO-6728.0%

CMPX-2635.0%

ROIC (TTM)

ALXO-8046.0%

CMPX-2994.0%

Cash

ALXO$23M

CMPX$35M

Debt

ALXO$11M

CMPX$0

Net Cash/Debt

ALXO$12M

CMPX$35M

Current Ratio (TTM)

ALXO9.71x

CMPX11.22x

Quick Ratio (TTM)

ALXO9.44x

CMPX11.15x

Debt/Equity (TTM)

ALXO0.08x

CMPX0.00x

Debt/Assets (TTM)

ALXO0.0%

CMPX0.0%

Interest Coverage (TTM)

ALXON/A

CMPXN/A

Net Debt/EBITDA (TTM)

ALXO0.00x

CMPX0.00x

Beta

ALXO0.55

CMPX1.07

52W Performance

ALXO-36.5%

CMPX-74.5%

YTD Performance

ALXO8.7%

CMPX-80.8%

% from 52W High

ALXO-53.0%

CMPX-85.6%

% from 52W Low

ALXO19.0%

CMPX19.7%

Asset Turnover (TTM)

ALXO0.00x

CMPX0.00x

FCF Yield (TTM)

ALXO-42.2%

CMPX-31.5%

Earnings Yield (TTM)

ALXO-48.1%

CMPX-16.8%

Dividend Yield (TTM)

ALXON/A

CMPXN/A

Rule of 40

ALXO0.0

CMPX0.0

EV/GP/RG

ALXON/A

CMPXN/A

Ticker research

View ALXO research View CMPX research

Metric	ALXO ALX Oncology Holdings Inc	CMPX Compass Therapeutics Inc.
Market & Valuation
Market Cap	$168M	$179M
Enterprise Value	$156M	$143M
Price	$1.25	$0.99
P/E Ratio	N/A	N/A
P/S Ratio	46.09x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.24x	0.93x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.20x	-2.54x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	1.51x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	357.6%	397.5%
Profitability
Gross Margin (TTM)	9.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-81M	$-30M
FCF (TTM)	$-71M	$-56M
EPS (TTM)	-$0.60	$0.00
ROE (TTM)	-9030.0%	-2994.0%
ROA (TTM)	-6728.0%	-2635.0%
ROIC (TTM)	-8046.0%	-2994.0%
Financial Health
Cash	$23M	$35M
Debt	$11M	$0
Net Cash/Debt	$12M	$35M
Current Ratio (TTM)	9.71x	11.22x
Quick Ratio (TTM)	9.44x	11.15x
Debt/Equity (TTM)	0.08x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.55	1.07
52W Performance	-36.5%	-74.5%
YTD Performance	8.7%	-80.8%
% from 52W High	-53.0%	-85.6%
% from 52W Low	19.0%	19.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-42.2%	-31.5%
Earnings Yield (TTM)	-48.1%	-16.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ALXO research	View CMPX research

Valuation

P/S Ratio

CMPX

0.00x

ALXO

46.09x

EV/FCF

CMPX

-2.54x

ALXO

-2.20x

Growth & revenue

Forward Revenue Growth

CMPX

397.5%

ALXO

357.6%

Profitability & performance

Gross Margin

ALXO

9.0%

CMPX

0.0%

ROE

CMPX

-2994.0%

ALXO

-9030.0%

FCF Yield %

CMPX

-31.5%

ALXO

-42.2%

52-Week Performance

ALXO

-36.5%

CMPX

-74.5%

Detailed metrics comparison

ALXO

ALX Oncology Holdings Inc

CMPX

Compass Therapeutics Inc.

Market Cap

ALXO$168M

CMPX$179M

Enterprise Value

ALXO$156M

CMPX$143M

Price

ALXO$1.25

CMPX$0.99

P/E Ratio

ALXON/A

CMPXN/A

P/S Ratio

ALXO46.09x

CMPX0.00x

EV/Sales

ALXO0.00x

CMPX0.00x

EV/EBITDA

ALXO0.00x

CMPX0.00x

P/B Ratio

ALXO1.24x

CMPX0.93x

P/FCF Ratio

ALXON/A

CMPXN/A

EV/FCF

ALXO-2.20x

CMPX-2.54x

PEG Ratio

ALXON/A

CMPXN/A

Forward P/E (NTM)

ALXON/A

CMPXN/A

Forward P/S (NTM)

ALXON/A

CMPX1.51x

Revenue (TTM)

ALXO$0

CMPX$0

Revenue Growth (YoY)

ALXON/A

CMPXN/A

Forward Rev Growth

ALXO357.6%

CMPX397.5%

Gross Margin (TTM)

ALXO9.0%

CMPX0.0%

Operating Margin (TTM)

ALXO0.0%

CMPX0.0%

EBITDA Margin (TTM)

ALXO0.0%

CMPX0.0%

Net Margin (TTM)

ALXO0.0%

CMPX0.0%

FCF Margin (TTM)

ALXON/A

CMPXN/A

Net Income (TTM)

ALXO$-81M

CMPX$-30M

FCF (TTM)

ALXO$-71M

CMPX$-56M

EPS (TTM)

ALXO-$0.60

CMPX$0.00

ROE (TTM)

ALXO-9030.0%

CMPX-2994.0%

ROA (TTM)

ALXO-6728.0%

CMPX-2635.0%

ROIC (TTM)

ALXO-8046.0%

CMPX-2994.0%

Cash

ALXO$23M

CMPX$35M

Debt

ALXO$11M

CMPX$0

Net Cash/Debt

ALXO$12M

CMPX$35M

Current Ratio (TTM)

ALXO9.71x

CMPX11.22x

Quick Ratio (TTM)

ALXO9.44x

CMPX11.15x

Debt/Equity (TTM)

ALXO0.08x

CMPX0.00x

Debt/Assets (TTM)

ALXO0.0%

CMPX0.0%

Interest Coverage (TTM)

ALXON/A

CMPXN/A

Net Debt/EBITDA (TTM)

ALXO0.00x

CMPX0.00x

Beta

ALXO0.55

CMPX1.07

52W Performance

ALXO-36.5%

CMPX-74.5%

YTD Performance

ALXO8.7%

CMPX-80.8%

% from 52W High

ALXO-53.0%

CMPX-85.6%

% from 52W Low

ALXO19.0%

CMPX19.7%

Asset Turnover (TTM)

ALXO0.00x

CMPX0.00x

FCF Yield (TTM)

ALXO-42.2%

CMPX-31.5%

Earnings Yield (TTM)

ALXO-48.1%

CMPX-16.8%

Dividend Yield (TTM)

ALXON/A

CMPXN/A

Rule of 40

ALXO0.0

CMPX0.0

EV/GP/RG

ALXON/A

CMPXN/A

Ticker research

View ALXO research View CMPX research

Metric	ALXO ALX Oncology Holdings Inc	CMPX Compass Therapeutics Inc.
Market & Valuation
Market Cap	$168M	$179M
Enterprise Value	$156M	$143M
Price	$1.25	$0.99
P/E Ratio	N/A	N/A
P/S Ratio	46.09x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.24x	0.93x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.20x	-2.54x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	1.51x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	357.6%	397.5%
Profitability
Gross Margin (TTM)	9.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-81M	$-30M
FCF (TTM)	$-71M	$-56M
EPS (TTM)	-$0.60	$0.00
ROE (TTM)	-9030.0%	-2994.0%
ROA (TTM)	-6728.0%	-2635.0%
ROIC (TTM)	-8046.0%	-2994.0%
Financial Health
Cash	$23M	$35M
Debt	$11M	$0
Net Cash/Debt	$12M	$35M
Current Ratio (TTM)	9.71x	11.22x
Quick Ratio (TTM)	9.44x	11.15x
Debt/Equity (TTM)	0.08x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.55	1.07
52W Performance	-36.5%	-74.5%
YTD Performance	8.7%	-80.8%
% from 52W High	-53.0%	-85.6%
% from 52W Low	19.0%	19.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-42.2%	-31.5%
Earnings Yield (TTM)	-48.1%	-16.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ALXO research	View CMPX research